Analysis of Brca1-deficient mouse mammary glands reveals reciprocal regulation of Brca1 and c-kit

Oncogene

Volumn 30, Issue 13, 2011, Pages 1597-1607

  Smart, C E ^a,b   Wronski, A ^a   French, J D ^a   Edwards, S L ^a   Asselin Labat, M L ^c   Waddell, N ^a   Peters, K ^a   Brewster, B L ^a   Brooks, K ^a   Simpson, K ^d   Manning, N ^d   Lakhani, S R ^b   Grimmond, S ^a   Lindeman, G J ^c   Visvader, J E ^c   Brown, M A ^a,d  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Brca1; c kit; expression profiling; luminal progenitor; mammary epithelial morphogenesis; mammary gland

Indexed keywords

BRCA1 PROTEIN; SMALL INTERFERING RNA; STEM CELL FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LACTATION; MAMMARY GLAND; MOUSE; NONHUMAN; ONCOGENE C KIT; PREGNANCY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL;

ANIMALS; BRCA1 PROTEIN; BREAST NEOPLASMS; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION PROFILING; LACTATION; MAMMARY GLANDS, ANIMAL; MICE; PREGNANCY; PROTO-ONCOGENE PROTEINS C-KIT; STEM CELLS;

MOUSE MAMMARY TUMOR VIRUS; MUS;

EID: 79953176619     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.538     Document Type: Article

References (55)

1. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. (2003). Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988. (Pubitemid 36418143)
2. Asselin-Labat ML, Sutherland KD, Barker H, Thomas R, Shackleton M, Forrest NC et al. (2007). Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol 9: 201-209. (Pubitemid 46420863)
3. Bektas N, Noetzel E, Veeck J, Press MF, Kristiansen G, Naami A et al. (2008). The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer. Breast Cancer Res 10: R58.
4. Bogorad RL, Courtillot C, Mestayer C, Bernichtein S, Harutyunyan L, Jomain JB et al. (2008). Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors. Proc Natl Acad Sci USA 105: 14533-14538.
5. Brown MA, Nicolai H, Howe K, Katagiri T, Lalani el N, Simpson KJ et al. (2002). Expression of a truncated Brca1 protein delays lactational mammary development in transgenic mice. Transgenic Res 11: 467-478. (Pubitemid 35255177)
6. Clarkson RW, Wayland MT, Lee J, Freeman T, Watson CJ. (2004). Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression. Breast Cancer Res 6: R92-109.
7. Cui Y, Miyoshi K, Claudio E, Siebenlist U, Gonzalez F. (2002). Loss of the peroxisome proliferation-activated receptor gamma (PPARg) does not affect mammary development and propensity for tumor formation but leads to reduced Fertility. J Biol Chem 277: 17830-17835. (Pubitemid 34967591)
8. Dunning MJ, Smith ML, Ritchie ME, Tavare S. (2007). Beadarray: R classes and methods for Illumina bead-based data. Bioinformatics 23: 2183-2184. (Pubitemid 47394121)
9. Felli N, Fontana L, Pelosi E, Botta R, Bonci D, Facchiano F et al. (2005). MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci USA 102: 18081-18086. (Pubitemid 41798505)
10. Foulkes WD, Stefansson IM, Chappuis PO, Begin LR, Goffin JR, Wong N et al. (2003). Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 95: 1482-1485. (Pubitemid 37279334)
11. Furuta S, Jiang X, Gu B, Cheng E, Chen PL, Lee WH. (2005). Depletion of BRCA1 impairs differentiation but enhances proliferation of mammary epithelial cells. Proc Natl Acad Sci USA 102: 9176-9181. (Pubitemid 40923537)
12. Hakem R, de la Pompa JL, Sirard C, Mo R, Woo M, Hakem A et al. (1996). The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 85: 1009-1023. (Pubitemid 26231168)
13. Hennighausen L, Robinson GW. (2001). Signaling pathways in mammary gland development. Dev Cell 1: 467-475. (Pubitemid 33586099)
14. Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z et al. (2007). Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol. 8: R76.
15. Jernstrom H, Johannsson O, Borg A, Olsson H. (1998). Do BRCAl mutations affect the ability to breast-feed? Significantly shorter length of breast-feeding among BRCAl mutation carriers compared with their unaffected relatives. The Breast 7: 320-324. (Pubitemid 29060398)
16. Kijima T, Maulik G, Ma PC, Tibaldi EV, Turner RE, Rollins B et al. (2002). Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells. Cancer Res 62: 6304-6311. (Pubitemid 35244485)
17. Kubista M, Rosner M, Kubista E, Bernaschek G, Hengstschlager M. (2002). Brca1 regulates in vitro differentiation of mammary epithelial cells. Oncogene 21: 4747-4756. (Pubitemid 34879450)
18. Lakhani SR, Jacquemier J, Sloane JP, Gusterson BA, Anderson TJ, van de Vijver MJ et al. (1998). Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 90: 1138-1145. (Pubitemid 28380718)
19. LaMarca HL, Rosen JM. (2008). Minireview: hormones and mammary cell fate-what will I become when I grow up? Endocrinology 149: 4317-4321.
20. Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH et al. (2009). Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 15: 907-913.
21. Liu S, Ginestier C, Charafe-Jauffret E, Foco H, Kleer CG, Merajver SD et al. (2008). BRCA1 regulates human mammary stem/progenitor cell fate. Proc Natl Acad Sci USA 105: 1680-1685. (Pubitemid 351346574)
22. Livak KJ, Schmittgen TD. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
23. Maddison K, Clarke AR. (2005). New approaches for modelling cancer mechanisms in the mouse. J Pathol. 205: 181-193. (Pubitemid 40227990)
24. Maia CJ, Socorro S, Schmitt F, Santos CR. (2008). Characterization of oligoadenylate synthetase-1 expression in rat mammary gland and prostate: effects of 17beta-estradiol on the regulation of OAS1 g in both tissues. Mol Cell Biochem 314: 113-121.
25. Master SR, Hartman JL, D'Cruz CM, Moody SE, Keiper EA, Ha SI et al. (2002). Functional microarray analysis of mammary organogenesis reveals a developmental role in adaptive thermogen-esis. Mol Endocrinol 16: 1185-1203. (Pubitemid 34621068)
26. Morgenstern JP, Land H. (1990). Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 18: 3587-3596.
27. Naylor MJ, Oakes SR, Gardiner-Garden M, Harris J, Blazek K, Ho TW et al. (2005). Transcriptional changes underlying the secretory activation phase of mammary gland development. Mol Endocrinol 19: 1868-1883. (Pubitemid 41007898)
28. Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z et al. (2004). Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10: 5367-5374. (Pubitemid 39100473)
29. Oakes SR, Naylor MJ, Asselin-Labat ML, Blazek KD, Gardiner-Garden M, Hilton HN et al. (2008). The Ets transcription factor Elf5 specifies mammary alveolar cell fate. Genes Dev 22: 581-586. (Pubitemid 351342431)
30. Pylayeva Y, Gillen KM, Gerald W, Beggs HE, Reichardt LF, Giancotti FG. (2009). Ras- and PI3K-dependent breast tumorigen-esis in mice and humans requires focal adhesion kinase signaling. J Clin Invest 119: 252.
31. Raafat A, Zoltan-Jones A, Strizzi L, Bargo S, Kimura K, Salomon D et al. (2007). Kit and PDGFR-alpha activities are necessary for Notch4/Int3-induced tumorigenesis. Oncogene 26: 662-672. (Pubitemid 46204246)
32. Russo J, Lynch H, Russo IH. (2001). Mammary gland architecture as a determining factor in the susceptibility of the human breast to cancer. Breast J 7: 278-291. (Pubitemid 33101632)
33. Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML et al. (2006). Generation of a functional mammary gland from a single stem cell. Nature 439: 84-88. (Pubitemid 43053633)
34. Shakya R, Szabolcs M, McCarthy E, Ospina E, Basso K, Nandula S et al. (2008). The basal-like mammary carcinomas induced by Brca1 or Bard1 inactivation implicate the BRCA1/BARD1 heterodimer in tumor suppression. Proc Natl Acad Sci USA 105: 7040-7045. (Pubitemid 351754526)
35. Sleeman KE, Kendrick H, Ashworth A, Isacke CM, Smalley MJ. (2006). CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells. Breast Cancer Res 8: R7.
36. Sleeman KE, Kendrick H, Robertson D, Isacke CM, Ashworth A, Smalley MJ. (2007). Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland. J Cell Biol 176: 19-26. (Pubitemid 46041676)
37. Smalley MJ, Titley I, Ashworth A. (2005). An improved definition of mouse mammary epithelial side population cells. Cytotherapy 7: 497-508. (Pubitemid 43078080)
38. Smart CE, Clarke C, Brooks KM, Raghavendra A, Brewster BL, French JD et al. (2008). Targeted disruption of Brca1 in restricted compartments of the mouse mammary epithelia. Breast Cancer Res Treat 112: 237-241.
39. Smyth GK, Michaud J, Scott HS. (2005). Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 21: 2067-2075. (Pubitemid 40668046)
40. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A et al. (2003). Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100: 8418-8423. (Pubitemid 36842560)
41. Stein T, Morris JS, Davies CR, Weber-Hall SJ, Duffy MA, Heath VJ et al. (2004). Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3. Breast Cancer Res 6: R75-R91.
42. Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, Choi D et al. (2006). Purification and unique properties of mammary epithelial stem cells. Nature 439: 993-997. (Pubitemid 43292419)
43. Triplett AA, Montagna C, Wagner KU. (2008). A mammary-specific, long-range deletion on mouse chromosome 11 accelerates Brca1-associated mammary tumorigenesis. Neoplasia 10: 1325-1334.
44. Tsai MH, Cook JA, Chandramouli GV, DeGraff W, Yan H, Zhao S et al. (2007). Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation. Cancer Res 67: 3845-3852. (Pubitemid 46762172)
45. Tsuda H, Tani Y, Weisenberger J, Kitada S, Hasegawa T, Murata T et al. (2005). Frequent KIT and epidermal growth factor receptor overexpressions in undifferentiated-type breast carcinomas with 'stem-cell-like' features. Cancer Sci 96: 333-339. (Pubitemid 41007467)
46. Usary J, Llaca V, Karaca G, Presswala S, Karaca M, He X et al. (2004). Mutation of GATA3 in human breast tumors. Oncogene 23: 7669-7678. (Pubitemid 39424925)
47. Vandenbark GR, Chen Y, Friday E, Pavlik K, Anthony B, deCastro C et al. (1996). Complex regulation of human c-kit transcription by promoter repressors, activators, and specific myb elements. Cell Growth Differ 7: 1383-1392. (Pubitemid 26360687)
48. Visvader JE, Lindeman GJ. (2008). Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nature reviews cancer 8: 755-768.
49. Wagner KU, Wall RJ, St-Onge L, Gruss P, Wynshaw-Boris A, Garrett L et al. (1997). Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res 25: 4323-4330. (Pubitemid 27485212)
50. Wagner KU, McAllister K, Ward T, Davis B, Wiseman R, Hennighausen L et al. (2001). Spatial and temporal expression of the Cre gene under the control of the MMTV-LTR in different lines of transgenic mice. Transgenic Res 10: 545-553. (Pubitemid 34043179)
51. Weiss RH. (2003). p21Waf1/Cip1 as a therapeutic target in breast and other cancers. Cancer Cell 4: 425-429. (Pubitemid 38050039)
52. Wright MH, Calcagno AM, Salcido CD, Carlson MD, Ambudkar SV, Varticovski L. (2008a). Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res 10: R10.
53. Wright MH, Robles AI, Herschkowitz JI, Hollingshead MG, Anver MR, Perou CM et al. (2008b). Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1. Mol Cancer 7: 29.
54. Xu X, Wagner KU, Larson D, Weaver Z, Li C, Ried T et al. (1999). Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet 22: 37-43. (Pubitemid 29214802)
55. Yamaji D, Na R, Feuermann Y, Pechhold S, Chen W, Robinson GW et al. (2009). Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A. Genes Dev 23: 2382-2387.